UK Watchdog Calls for Comprehensive AI Healthcare Legislation
The UK's medicines regulator has called for new legislation governing artificial intelligence in healthcare, warning that current regulatory frameworks are insufficient to address the complexities and risks of AI-driven medical technologies.
The Medicines and Healthcare products Regulatory Agency (MHRA) argues that AI systems in healthcare—from diagnostic imaging tools to treatment recommendation algorithms—require dedicated legal oversight that existing rules do not adequately provide. The watchdog contends that while current regulations cover medical devices and pharmaceuticals, they lack specific provisions for the dynamic, adaptive nature of AI systems that can learn and evolve after deployment.
Key concerns driving the call for new laws include ensuring AI medical devices maintain safety standards throughout their operational lives, establishing clear accountability when AI systems contribute to patient harm, and creating transparent reporting mechanisms for adverse outcomes involving AI-assisted care.
The proposed regulatory approach would likely introduce requirements for continuous monitoring of AI systems post-market approval, mandatory disclosure of when AI is used in patient care decisions, and clearer pathways for patients to seek recourse if harmed by AI-driven treatments or diagnoses.
Healthcare AI developers have generally supported the initiative, noting that clear regulatory expectations could actually accelerate responsible innovation by providing certainty about compliance requirements. Patient advocacy groups have emphasized the importance of balancing innovation with robust safety guarantees.
The watchdog's recommendations align with broader international discussions about AI governance, as regulators worldwide grapple with how to foster beneficial AI development while protecting public safety in high-stakes applications like healthcare.